March 22, 2022 — Centene Corporation (NYSE: CNC) today announced that Sarah London, Vice President of Centene, has been named Chief Executive Officer, effective immediately, succeeding Michael Neidoff. Mr. Neidorff remains on previously announced sick leave from his position on the Company’s Board of Directors.
Ms. London has spent her career at the forefront of healthcare innovation. She has focused on promoting integrated, value-based models of care through the development and application of data-driven ideas and technologies.
Prior to her appointment as CEO, Ms. London served as Vice Chairman of Centene’s Board of Directors. In her leadership role, Ms. London led the company’s technology and digital strategy in addition to leading the Healthcare and Specialty Enterprises, Corporate Strategy, Quality Operations, Internal Audit, Compliance and Risk Management divisions. Since Mr. Neidorff began sick leave in February 2022, she has been a member of the Office of the President responsible for leading the day-to-day management of the Company.
“I am delighted that the board has appointed Sarah as CEO. Her strategic thinking, fresh perspective and vast experience make her the natural leader to unlock Centene’s potential,” said James Dallas, Acting President of Centene. “Sarah has instilled an innovative mindset throughout the company in her relentless efforts to improve Centene’s abilities to provide the highest quality care to our members. I have always been impressed by Sarah’s passion for serving our members, who are often the most vulnerable among us. The Board and I believe she is the right visionary leader to drive value for our shareholders and write the next chapter in Centene’s growth. »
“I am humbled and honored to have been chosen as Centene’s next CEO and to work alongside amazing colleagues to provide quality health care to more than 26 million Americans,” said Ms. London. “The healthcare landscape is changing rapidly and Centene’s mission – transforming the health of our communities one member at a time – has never been more relevant. We have a unique opportunity to empower our members, suppliers and their communities in this transformation. Together, we can provide innovative, integrated and equitable care that meets our members where they live and exceeds their expectations. I am excited about the incredible opportunity to leverage the size and scale of this company to create real, sustainable value for our members, state partners, employees and shareholders.
“I would also like to thank Michael Neidoff, Centene’s visionary leader for over 25 years. Michael has built one of the great success stories of American business, and his commitment to providing affordable, high-quality health care to our fellow citizens will remain a foundation of this company into the future,” said Ms. London.
Brent Layton, President and COO of Centene, said, “Sarah brings a tremendous set of skills to the leadership of Centene Corporation, and I am delighted to work closely with her as Centene begins our journey to next era of our history.
Drew Asher, CFO of Centene, said, “Sarah brings a modern vision to the helm of one of this country’s premier healthcare companies. I am thrilled to be part of this leadership team and strongly believe in the potential of this company to continue its remarkable history of achievement within the healthcare industry.
About Sarah London
Sarah London is the President and CEO of Centene Corporation, a diversified health care company providing a portfolio of government-sponsored health care programs focused on the underinsured and uninsured to more than 26 million Americans. .
Prior to her appointment as CEO, Ms. London served as Vice President of the company and, in her leadership role, was responsible for a portfolio of businesses independent of Centene’s health plans, building differentiated platform capabilities and delivering leading products and services to third-party customers. Ms. London was previously the company’s senior vice president of technology innovation and modernization, responsible for enterprise-wide technology strategy and execution, with a focus on products and services. new generation.
Prior to joining Centene in 2020, Ms. London was a partner at Optum Ventures, the venture capital arm of UnitedHealth Group. Prior to Optum Ventures, Ms. London held the position of Product Manager for Optum Analytics, the business unit responsible for strategy and commercialization of Optum’s integrated data and analytics solutions in the provider, payer and and life sciences.
Ms. London previously served as Vice President of Client Services and Operations at Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013.
Prior to joining Humedica, Ms. London was part of the team that launched Accretive Health’s Quality and Total Cost of Care business, providing end-to-end population health strategy and operational guidance to leading medical centers. from the country.
Ms. London began her healthcare career with Health Leads, a nationally recognized social enterprise that partners with healthcare organizations to address the social determinants of health by connecting patients to resources. needed to support high-quality, cost-effective health outcomes.
Ms. London holds an MBA with high honors from the University of Chicago Booth School of Business and a BA Magna Cum Laude in History and Literature from Harvard College, where she played Division I tennis.
About Centene Corporation
Centene Corporation, a Fortune 25 company, is a leading healthcare company committed to helping people live healthier lives. The company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, cost-effective services to government-sponsored and commercial healthcare programs, focusing on the underinsured and uninsured. Centene provides affordable, high-quality products to nearly 1 in 15 people nationwide, including Medicaid and Medicare members (including Medicare prescription drug plans) and individuals and families served by the health insurance market, the TRICARE program and people in correctional facilities. The Company also serves several international markets and contracts with other healthcare and commercial organizations to provide a variety of specialized services focused on treating the whole person. Centene is focused on long-term growth and value creation as well as developing its people, systems and capabilities to better serve its members, suppliers, local communities and government partners.
Centene uses its Investor Relations website to post important information about the Company, including information that investors may believe is important. Financial and other information about Centene is published regularly and can be accessed on Centene’s Investor Relations website, https://investors.centene.com/.